194 related articles for article (PubMed ID: 20550708)
1. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK
Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014
[TBL] [Abstract][Full Text] [Related]
3. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
[TBL] [Abstract][Full Text] [Related]
4. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
[TBL] [Abstract][Full Text] [Related]
5. Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.
Ghadersohi A; Sharma S; Zhang S; Azrak RG; Wilding GE; Manjili MH; Li F
Prostate; 2011 Aug; 71(11):1178-88. PubMed ID: 21656828
[TBL] [Abstract][Full Text] [Related]
6. PDEF downregulates stathmin expression in prostate cancer.
Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M
Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487
[TBL] [Abstract][Full Text] [Related]
7. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
Pal M
J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
[TBL] [Abstract][Full Text] [Related]
8. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
[TBL] [Abstract][Full Text] [Related]
9. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
10. PDEF is a negative regulator of colon cancer cell growth and migration.
Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK
J Cell Biochem; 2009 Dec; 108(6):1389-98. PubMed ID: 19830706
[TBL] [Abstract][Full Text] [Related]
11. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
[TBL] [Abstract][Full Text] [Related]
12. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
14. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
Ghadersohi A; Odunsi K; Zhang S; Azrak RG; Bundy BN; Manjili MH; Li F
Int J Cancer; 2008 Sep; 123(6):1376-84. PubMed ID: 18567002
[TBL] [Abstract][Full Text] [Related]
15. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
16. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
[TBL] [Abstract][Full Text] [Related]
17. PDEF in prostate cancer.
Sood AK; Kim H; Geradts J
Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
[TBL] [Abstract][Full Text] [Related]
18. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
Turner DP; Findlay VJ; Kirven AD; Moussa O; Watson DK
Mol Biol Cell; 2008 Sep; 19(9):3745-57. PubMed ID: 18579687
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.
Findlay VJ; Turner DP; Moussa O; Watson DK
Cancer Res; 2008 Oct; 68(20):8499-506. PubMed ID: 18922924
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.
Situ J; Zhang H; Lu L; Li K; Hu C; Wang DJ
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3347-3352. PubMed ID: 28829509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
